Christoph Kimmich

2.1k total citations
54 papers, 1.4k citations indexed

About

Christoph Kimmich is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Christoph Kimmich has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 14 papers in Genetics and 14 papers in Oncology. Recurrent topics in Christoph Kimmich's work include Amyloidosis: Diagnosis, Treatment, Outcomes (40 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Christoph Kimmich is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (40 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Christoph Kimmich collaborates with scholars based in Germany, United States and Italy. Christoph Kimmich's co-authors include Ute Hegenbart, Stefan Schönland, Anthony D. Ho, Anna Jauch, Tobias Dittrich, Hartmut Goldschmidt, Tilmann Bochtler, Giampaolo Merlini, Paolo Milani and Andrea Foli and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christoph Kimmich

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Kimmich Germany 21 1.2k 443 285 278 264 54 1.4k
Nagaaki Katoh Japan 14 379 0.3× 80 0.2× 162 0.6× 42 0.2× 133 0.5× 61 647
Stephen B. Marley United Kingdom 16 394 0.3× 264 0.6× 281 1.0× 384 1.4× 13 0.0× 23 956
Gidi Rechavi Israel 17 614 0.5× 98 0.2× 265 0.9× 129 0.5× 16 0.1× 26 1.1k
Monica Schaller Switzerland 15 249 0.2× 116 0.3× 37 0.1× 116 0.4× 114 0.4× 28 880
Hirofumi Amano Japan 20 195 0.2× 53 0.1× 115 0.4× 76 0.3× 53 0.2× 64 1.2k
Kentaro Minagawa Japan 19 383 0.3× 104 0.2× 356 1.2× 346 1.2× 22 0.1× 61 1.0k
Mercedes Guerrero-Esteo Spain 8 529 0.5× 214 0.5× 118 0.4× 42 0.2× 30 0.1× 9 909
Ingrid Raab Austria 10 391 0.3× 86 0.2× 685 2.4× 18 0.1× 112 0.4× 10 1.2k
Haruko Shima Japan 13 505 0.4× 266 0.6× 190 0.7× 593 2.1× 5 0.0× 34 1.2k

Countries citing papers authored by Christoph Kimmich

Since Specialization
Citations

This map shows the geographic impact of Christoph Kimmich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Kimmich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Kimmich more than expected).

Fields of papers citing papers by Christoph Kimmich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Kimmich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Kimmich. The network helps show where Christoph Kimmich may publish in the future.

Co-authorship network of co-authors of Christoph Kimmich

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Kimmich. A scholar is included among the top collaborators of Christoph Kimmich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Kimmich. Christoph Kimmich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berends, M, Peter van der Meer, Riemer H. J. A. Slart, et al.. (2025). Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging. 52(13). 5000–5005.
2.
Metzner, Bernd, Thomas Müller, Jochen Casper, et al.. (2024). Secondary Malignancies After Autologous Stem Cell Transplantations in Patients With Malignant Lymphoma and Multiple Myeloma. European Journal Of Haematology. 114(3). 536–544. 2 indexed citations
3.
4.
Metzner, Bernd, Thomas Müller, Jochen Casper, et al.. (2023). Long‐term outcome in patients with mantle cell lymphoma following high‐dose therapy and autologous stem cell transplantation. European Journal Of Haematology. 111(2). 220–228. 1 indexed citations
5.
Hinderhofer, Katrin, Julian Baur, Christian Haupt, et al.. (2022). Lysozyme amyloidosis—a report on a large German cohort and the characterisation of a novel amyloidogenic lysozyme gene variant. Amyloid. 29(4). 245–254. 11 indexed citations
6.
Metzner, Bernd, Thomas Müller, Jochen Casper, et al.. (2021). Long-term remissions in patients with early relapse of diffuse large B-cell lymphoma following high-dose chemotherapy, autologous stem cell transplantation, and radiotherapy of residual disease. Strahlentherapie und Onkologie. 198(1). 39–46. 3 indexed citations
7.
Ungerer, Matthias N., Ernst Hund, Jan Purrucker, et al.. (2020). Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience. Amyloid. 28(2). 91–99. 12 indexed citations
8.
Kimmich, Christoph, Tobias Terzer, Axel Benner, et al.. (2020). Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria. Blood. 135(18). 1517–1530. 61 indexed citations
9.
Milani, Paolo, Faye Sharpley, Stefan Schönland, et al.. (2020). Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patients. Amyloid. 27(4). 231–236. 25 indexed citations
10.
Dittrich, Tobias, Christoph Kimmich, Ute Hegenbart, & Stefan Schönland. (2020). Prognosis and Staging of AL Amyloidosis. Acta Haematologica. 143(4). 388–400. 30 indexed citations
11.
Heußel, Claus Peter, Hans‐Ulrich Kauczor, Christoph Röcken, et al.. (2020). CT features in amyloidosis of the respiratory system – Comprehensive analysis in a tertiary referral center cohort. European Journal of Radiology. 129. 109123–109123. 10 indexed citations
12.
Seckinger, Anja, Jens Hillengaß, Martina Emde, et al.. (2018). CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance. Frontiers in Immunology. 9. 1676–1676. 32 indexed citations
13.
Kollmer, Jennifer, Markus Weiler, Jan Purrucker, et al.. (2018). MR neurography biomarkers to characterize peripheral neuropathy in AL amyloidosis. Neurology. 91(7). e625–e634. 29 indexed citations
14.
Kimmich, Christoph, Stefan Schönland, Anthony D. Ho, et al.. (2017). Daratumumab Monotherapy in Thirty-Two Heavily Pre-Treated Patients with Advanced Systemic Light-Chain Amyloidosis. Blood. 130. 1837–1837. 10 indexed citations
15.
Kimmich, Christoph, Stefan Schönland, Mindaugas Andrulis, et al.. (2017). Amyloid in bone marrow smears in systemic light-chain amyloidosis. Amyloid. 24(1). 52–59. 17 indexed citations
16.
Bochtler, Tilmann, Ute Hegenbart, Christina Kunz, et al.. (2016). Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study. Blood. 128(4). 594–602. 53 indexed citations
17.
Bochtler, Tilmann, Ute Hegenbart, Christina Kunz, et al.. (2015). Translocation t(11;14) Is Associated With Adverse Outcome in Patients With Newly Diagnosed AL Amyloidosis When Treated With Bortezomib-Based Regimens. Journal of Clinical Oncology. 33(12). 1371–1378. 153 indexed citations
18.
Palladini, Giovanni, Ute Hegenbart, Paolo Milani, et al.. (2014). A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood. 124(15). 2325–2332. 300 indexed citations
19.
Kollmer, Jennifer, Ernst Hund, Ute Hegenbart, et al.. (2014). In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography. Brain. 138(3). 549–562. 109 indexed citations
20.
Kimmich, Christoph & Peter Hoffmann. (1977). The History of the German Resistance 1933-1945. Foreign Affairs. 55(4). 913–913. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nagaaki Katoh Breakdown of academic impact, for papers by Stephen B. Marley Breakdown of academic impact, for papers by Gidi Rechavi Breakdown of academic impact, for papers by Monica Schaller Breakdown of academic impact, for papers by Hirofumi Amano Breakdown of academic impact, for papers by Kentaro Minagawa Breakdown of academic impact, for papers by Mercedes Guerrero-Esteo Breakdown of academic impact, for papers by Ingrid Raab Breakdown of academic impact, for papers by Haruko Shima
Rankless by CCL
2026